Merck
MRK
#58
Rank
HK$2.227 T
Marketcap
HK$902.03
Share price
0.23%
Change (1 day)
41.94%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): HK$27.70

According to Merck's latest financial reports the company's current EPS (TTM) is HK$27.86. In 2025 the company made an earnings per share (EPS) of HK$57.08 an increase over its 2024 EPS that were of HK$52.94.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$27.70-51.46%
2025HK$57.087.81%
2024HK$52.944308.46%
2023HK$1.20-97.32%
2022HK$44.8810.92%
2021HK$40.4684.68%
2020HK$21.91-27.2%
2019HK$30.0963.44%
2018HK$18.41151.11%
2017HK$7.33-54.58%
2016HK$16.1430.21%
2015HK$12.40-61.99%
2014HK$32.61180.51%
2013HK$11.63-31.82%
2012HK$17.056.62%
2011HK$15.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.42 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$54.98 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.26-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$28.26 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.06 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.41 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$20.05-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$27.88 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.44 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$10.73-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel